NASDAQ:IOVA
Iovance Biotherapeutics, Inc.
- Stock
Last Close
10.43
17/05 20:00
Market Cap
1.94B
Beta: 0.20
Volume Today
4.45M
Avg: 3.51M
PE Ratio
−4.56
PFCF: −7.39
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -25.38M - | -12.03M 52.58% | -27.66M 129.84% | -52.89M 91.23% | -92.06M 74.05% | -123.58M 34.23% | -197.56M 59.86% | -259.58M 31.40% | -342.25M 31.85% | -395.89M 15.67% | -444.04M 12.16% | |
depreciation and amortization | 7.09K - | 88.22K 1,144.83% | 999K 1,032.38% | 978K 2.10% | 952K 2.66% | 956K 0.42% | 1.17M 22.28% | 1.14M 2.48% | 13.98M 1,126.32% | 21.14M 51.18% | 33.13M 56.74% | |
deferred income tax | -3.40M - | 1.86M 154.77% | -3.48M - | |||||||||
stock based compensation | 18.90M - | 11.97M 36.69% | 20.03M 67.34% | 24.28M 21.22% | 40.89M 68.42% | 69.77M 70.63% | 84.02M 20.44% | 62.63M 25.47% | ||||
change in working capital | -264.26K - | -500.59K 89.43% | -243K 51.46% | 418K 272.02% | 416K 0.48% | 2.67M 542.07% | 10.01M 274.69% | 2.98M 70.19% | 24.55M 723.10% | -2.89M 111.78% | -6.52M 125.48% | |
accounts receivables | -149K - | |||||||||||
inventory | -10.12M - | |||||||||||
accounts payables | -543.56K - | -354.94K 34.70% | -32K 90.98% | -250K 681.25% | 369K 247.60% | 1.51M 308.40% | 12.71M 743.13% | -2.96M 123.33% | 6.98M 335.36% | 5.88M 15.67% | 4.83M 17.93% | |
other working capital | 279.30K - | -145.65K 152.15% | -211K 44.87% | 668K 416.59% | 47K 92.96% | 1.16M 2,376.60% | -2.70M 331.79% | 5.95M 320.42% | 17.58M 195.56% | -8.78M 149.92% | -1.08M 87.67% | |
other non cash items | 21.98M - | 3.81M 82.65% | 8.52M 123.48% | -74K 100.87% | 19K 125.68% | -1.32M 7,063.16% | 6.62M 600.23% | 7.57M 14.42% | 6.01M 20.59% | 871K 85.51% | -3.54M 505.86% | |
net cash provided by operating activities | -3.66M - | -8.63M 135.74% | -18.38M 112.91% | -32.67M 77.73% | -78.71M 140.94% | -101.25M 28.64% | -158.89M 56.93% | -205.13M 29.11% | -227.94M 11.12% | -292.76M 28.44% | -361.82M 23.59% | |
investments in property plant and equipment | -12.71K - | -1.59M 12,430.74% | -1.14M 28.20% | -1.52M 33.07% | -1.03M 32.41% | -1.20M 16.54% | -6.92M 477.38% | -46.79M 576.46% | -37.57M 19.70% | -20.43M 45.64% | -22.29M 9.13% | |
acquisitions net | 19.95M - | -96.94M - | 271.06M 379.61% | -37.71M 113.91% | -276.88M 634.31% | -212.63M 23.20% | ||||||
purchases of investments | -160.61M - | -110.25M 31.36% | -426.08M - | -417.66M 1.98% | -947.66M 126.90% | -725.21M 23.47% | -245.82M 66.10% | -205.90M 16.24% | ||||
sales maturities of investments | 70.60M - | 120.66M 70.91% | 59.70M 50.52% | 41M 31.33% | 514.60M 1,155.12% | 676.60M 31.48% | 762.91M 12.76% | 522.70M 31.49% | 285.58M 45.36% | |||
other investing activites | -19.95M - | 96.94M - | -271.06M 379.61% | 37.71M 113.91% | 276.88M 634.31% | |||||||
net cash used for investing activites | -12.71K - | -1.59M 12,430.74% | -91.15M 5,625.58% | 8.89M 109.76% | 58.68M 559.74% | -386.28M 758.31% | 90.03M 123.31% | -317.85M 453.07% | 132K 100.04% | 256.45M 194,184.09% | -155.24M 160.53% | |
debt repayment | -1M - | |||||||||||
common stock issued | 7.13M - | 32.24M 352.38% | 68.31M 111.87% | 95.69M 40.08% | 53.66M 43.92% | 398.82M 643.20% | 6.13M 98.46% | 567.04M 9,148.78% | 203.16M 64.17% | 189.50M 6.72% | 465.75M 145.78% | |
common stock repurchased | -312K - | -284K 8.97% | 1.59M 658.45% | 1.66M 4.35% | 2.41M 45.62% | |||||||
dividends paid | -49.45M - | -1M - | ||||||||||
other financing activites | 16.22M - | 3.22M 80.14% | 9.96M 209.14% | 50.67M 408.77% | 5.03M 90.08% | 25.49M 407.16% | 312K 98.78% | 9.66M 2,997.12% | 36.53M 278.00% | -1.01M 102.76% | -5.21M 416.88% | |
net cash used provided by financing activities | 23.35M - | 35.46M 51.89% | 78.27M 120.71% | 96.90M 23.81% | 58.69M 39.44% | 424.31M 622.99% | 6.13M 98.56% | 576.42M 9,301.76% | 239.27M 58.49% | 190.15M 20.53% | 462.96M 143.47% | |
effect of forex changes on cash | 1 - | -2.74M - | ||||||||||
net change in cash | 19.67M - | 25.24M 28.29% | -31.27M 223.89% | 73.13M 333.89% | 38.66M 47.14% | -63.22M 263.55% | -62.73M 0.77% | 53.44M 185.18% | 11.46M 78.56% | 153.85M 1,242.60% | -116.84M 175.95% | |
cash at beginning of period | 19.67M - | 44.91M 128.29% | 33.59M 25.21% | 106.72M 217.73% | 145.37M 36.22% | 82.15M 43.49% | 19.42M 76.36% | 72.85M 275.17% | 84.31M 15.73% | 231.73M 174.85% | ||
cash at end of period | 19.67M - | 44.91M 128.29% | 13.64M 69.62% | 106.72M 682.27% | 145.37M 36.22% | 82.15M 43.49% | 19.42M 76.36% | 72.85M 275.17% | 84.31M 15.73% | 238.16M 182.47% | 114.89M 51.76% | |
operating cash flow | -3.66M - | -8.63M 135.74% | -18.38M 112.91% | -32.67M 77.73% | -78.71M 140.94% | -101.25M 28.64% | -158.89M 56.93% | -205.13M 29.11% | -227.94M 11.12% | -292.76M 28.44% | -361.82M 23.59% | |
capital expenditure | -12.71K - | -1.59M 12,430.74% | -1.14M 28.20% | -1.52M 33.07% | -1.03M 32.41% | -1.20M 16.54% | -6.92M 477.38% | -46.79M 576.46% | -37.57M 19.70% | -20.43M 45.64% | -22.29M 9.13% | |
free cash flow | -3.67M - | -10.23M 178.25% | -19.52M 90.94% | -34.19M 75.11% | -79.74M 133.22% | -102.45M 28.48% | -165.81M 61.85% | -251.93M 51.94% | -265.51M 5.39% | -313.18M 17.95% | -384.11M 22.65% |
All numbers in USD (except ratios and percentages)